This inventor holds 1 USPTO granted patent. Top assignee: Allelix Biopharmaceuticals Inc.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Oingchang Meng: Innovator in Indole Compounds
Introduction
Oingchang Meng is a notable inventor based in Georgetown, California. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on indole compounds. His research focuses on compounds that are selective for 5-HT1D-like receptors, which have important implications in various therapeutic areas.
Latest Patents
Oingchang Meng holds a patent for 5-alkenyl and 5-alkynyl indole compounds. This patent describes compounds that exhibit selectivity for 5-HT1D-like receptors, featuring a general formula that includes various substituents. His work in this area is crucial for the development of new therapeutic agents.
Career Highlights
Throughout his career, Oingchang Meng has been associated with Allelix Biopharmaceuticals Inc., where he has contributed to groundbreaking research and development. His expertise in the field has led to advancements in understanding receptor selectivity and its applications in medicine.
Collaborations
Oingchang has collaborated with esteemed colleagues such as Abdelmalik Slassi and Louise G Edwards. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Oingchang Meng's contributions to the field of biopharmaceuticals, particularly through his patent on indole compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic development.